Cordasco Financial Network’s Adicet Bio ACET Stock Holding History

Cordasco Financial Network’s Portfolio ACET Stock Details ACET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$0	Hold	1	–	–	﹤0.01%	582
2022 Q1	$0	Buy	+1	New	+$230	﹤0.01%	548

Other funds holding ACET

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cordasco Financial Network's ACET Position: Q2 2022 in Review

Cordasco Financial Network held its Adicet Bio (ACET) position steady in Q2 2022 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #582.

Cordasco Financial Network first reported a position in ACET in Q1 2022 and has held it in 2 quarters since. 101 funds tracked by Wall St. Rank hold ACET as of Q2 2022.

Cordasco Financial Network held 1 share of Adicet Bio worth $0 as of Q2 2022.
Cordasco Financial Network left its Adicet Bio share count unchanged in Q2 2022.
Adicet Bio made up ﹤0.01% of Cordasco Financial Network's portfolio in Q2 2022, its #582 holding.
Cordasco Financial Network first reported a position in Adicet Bio in Q1 2022 and has held it in 2 quarters since.
101 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2022.

Based on Cordasco Financial Network's 13F filing for Q2 2022, filed 15 Jul 2022.